Published in Bipolar Disord on May 05, 2014
Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker. Early Interv Psychiatry (2015) 1.42
Integrated neurobiology of bipolar disorder. Front Psychiatry (2014) 0.93
Toward the Definition of a Bipolar Prodrome: Dimensional Predictors of Bipolar Spectrum Disorders in At-Risk Youths. Am J Psychiatry (2016) 0.86
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses. Neuropsychiatr Dis Treat (2015) 0.82
The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls. Bipolar Disord (2014) 0.80
Molecular circadian rhythm shift due to bright light exposure before bedtime is related to subthreshold bipolarity. Sci Rep (2016) 0.77
The role of rumination in illness trajectories in youth: linking trans-diagnostic processes with clinical staging models. Psychol Med (2016) 0.76
Early Recognition of High Risk of Bipolar Disorder and Psychosis: An Overview of the ZInEP "Early Recognition" Study. Front Public Health (2014) 0.76
Early interventions for youths at high risk for bipolar disorder: a developmental approach. Eur Child Adolesc Psychiatry (2015) 0.76
Bipolar At-risk Criteria: An Examination of Which Clinical Features Have Optimal Utility for Identifying Youth at Risk of Early Transition From Depression to Bipolar Disorders. Schizophr Bull (2016) 0.76
The usefulness for indicated prevention of severe mental disorders should play a central part in the further development of CBT. World Psychiatry (2014) 0.75
Concepts and misconceptions regarding clinical staging models. J Psychiatry Neurosci (2016) 0.75
Prodrome or risk syndrome: what's in a name? Int J Bipolar Disord (2017) 0.75
Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits. Psychiatry Res (2016) 0.75
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry (2012) 5.45
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry (2005) 5.17
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry (2002) 4.06
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 3.86
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry (2006) 3.62
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res (2004) 3.55
The elephant on the couch: side-effects of psychotherapy. Aust N Z J Psychiatry (2009) 3.31
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res (2013) 3.01
Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry (2010) 2.99
Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry (2008) 2.89
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry (2006) 2.60
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull (2007) 2.56
Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res (2008) 2.45
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol (2008) 2.44
Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry (2012) 2.39
Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. J Clin Psychiatry (2012) 2.31
Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust (2007) 2.25
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull (2005) 2.13
Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem (2009) 2.13
The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull (2003) 2.05
Group-based psychosocial intervention for bipolar disorder: randomised controlled trial. Br J Psychiatry (2010) 2.02
The role of alprazolam for the treatment of panic disorder in Australia. Aust N Z J Psychiatry (2012) 2.02
Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatry (2013) 2.02
Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale. Aust N Z J Psychiatry (2012) 2.02
A survey of combination antidepressant use in Australia. Australas Psychiatry (2007) 1.98
Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res (2009) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.97
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages. Med J Aust (2007) 1.91
The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology (2008) 1.88
Maternal and early postnatal nutrition and mental health of offspring by age 5 years: a prospective cohort study. J Am Acad Child Adolesc Psychiatry (2013) 1.87
Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull (2009) 1.85
Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry (2005) 1.84
Australian mental health reform: time for real outcomes. Med J Aust (2005) 1.81
Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry (2011) 1.77
Vocational intervention in first-episode psychosis: individual placement and support v. treatment as usual. Br J Psychiatry (2008) 1.74
The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta (2013) 1.72
PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust (2007) 1.72
Pituitary volume in psychosis. Br J Psychiatry (2004) 1.70
Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry (2009) 1.70
Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry (2003) 1.67
Moving towards a population health approach to the primary prevention of common mental disorders. BMC Med (2012) 1.65
Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Can J Psychiatry (2010) 1.64
The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J Clin Psychiatry (2010) 1.64
Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry (2006) 1.62
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology (2007) 1.61
Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull (2012) 1.58
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
Abnormalities in osteoclastogenesis and decreased tumorigenesis in mice deficient for ovarian cancer G protein-coupled receptor 1. PLoS One (2009) 1.55
Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull (2006) 1.54
N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther (2008) 1.54
Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Lipid Res (2010) 1.53
The association between habitual diet quality and the common mental disorders in community-dwelling adults: the Hordaland Health study. Psychosom Med (2011) 1.52
Oxidative pathways as a drug target for the treatment of autism. Expert Opin Ther Targets (2010) 1.51
The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophr Res (2009) 1.46
Pilot study evaluating the effect of massage therapy on stress, anxiety and aggression in a young adult psychiatric inpatient unit. Aust N Z J Psychiatry (2008) 1.46
Psychological needs of adolescents in the early phase of bipolar disorder: implications for early intervention. Early Interv Psychiatry (2011) 1.46
Childhood trauma and psychotic disorders: a systematic, critical review of the evidence. Schizophr Bull (2007) 1.45
N-acetylcysteine for major depressive episodes in bipolar disorder. Rev Bras Psiquiatr (2011) 1.43
The psychosis threshold in Ultra High Risk (prodromal) research: is it valid? Schizophr Res (2010) 1.43
Diagnosis of myalgic encephalomyelitis: where are we now? Expert Opin Med Diagn (2013) 1.43
Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry (2013) 1.43
Risk, disorder and diagnosis. Aust N Z J Psychiatry (2011) 1.42
Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry (2007) 1.41
Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski-/- mice. Nat Genet (2001) 1.39
Guidelines for youth depression: time to incorporate new perspectives. Med J Aust (2010) 1.39
Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res (2006) 1.38
Bipolar disorder: new understandings, emerging treatments. Med J Aust (2010) 1.38
Depolarizing bipolar disorder: both the illness and our views. Aust N Z J Psychiatry (2011) 1.38
Funding for mental health research: the gap remains. Med J Aust (2011) 1.38
A prospective study of diet quality and mental health in adolescents. PLoS One (2011) 1.38
Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability. Schizophr Bull (2005) 1.38
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med (2012) 1.37
Increased access to evidence-based primary mental health care: will the implementation match the rhetoric? Med J Aust (2007) 1.36
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci (2011) 1.35